TREATMENT OF PARKINSONS-DISEASE WITH AGENTS OTHER THAN LEVODOPA AND DOPAMINE AGONISTS - CONTROVERSIES AND NEW APPROACHES

被引:34
作者
LANG, AE
机构
关键词
D O I
10.1017/S0317167100046436
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:210 / 220
页数:11
相关论文
共 146 条
  • [11] NOMIFENSINE IN PARKINSONS-DISEASE
    BEDARD, P
    PARKES, JD
    MARSDEN, CD
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 4 : S187 - S190
  • [12] EFFECT OF NEW DOPAMINE-BLOCKING AGENT (OXIPEROMIDE) ON DRUG-INDUCED DYSKINESIAS IN PARKINSONS-DISEASE AND SPONTANEOUS DYSKINESIAS
    BEDARD, P
    PARKES, JD
    MARSDEN, CD
    [J]. BRITISH MEDICAL JOURNAL, 1978, 1 (6118) : 954 - 956
  • [13] BIRKMAYE.W, 1972, NERVENARZT, V43, P76
  • [14] POTENTIATION OF ANTI AKINETIC EFFECT AFTER L-DOPA TREATMENT BY AN INHIBITOR OF MAO-B, DEPRENIL
    BIRKMAYER, W
    RIEDERER, P
    YOUDIM, MBH
    LINAUER, W
    [J]. JOURNAL OF NEURAL TRANSMISSION, 1975, 36 (3-4) : 303 - 326
  • [15] BIRKMAYER W, 1962, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V203, P560, DOI 10.1007/BF00343235
  • [16] (-)DEPRENYL IN THE TREATMENT OF PARKINSONS-DISEASE
    BIRKMAYER, W
    RIEDERER, P
    YOUDIM, MBH
    [J]. CLINICAL NEUROPHARMACOLOGY, 1982, 5 (02) : 195 - 230
  • [17] BIRKMAYER W, 1977, LANCET, V1, P439
  • [18] ENDORPHINS - PROFOUND BEHAVIORAL-EFFECTS IN RATS SUGGEST NEW ETIOLOGICAL FACTORS IN MENTAL-ILLNESS
    BLOOM, F
    SEGAL, D
    LING, N
    GUILLEMIN, R
    [J]. SCIENCE, 1976, 194 (4265) : 630 - 632
  • [19] (-) BACLOFEN DECREASES NEUROTRANSMITTER RELEASE IN THE MAMMALIAN CNS BY AN ACTION AT A NOVEL GABA RECEPTOR
    BOWERY, NG
    HILL, DR
    HUDSON, AL
    DOBLE, A
    MIDDLEMISS, DN
    SHAW, J
    TURNBULL, M
    [J]. NATURE, 1980, 283 (5742) : 92 - 94
  • [20] BROLL M, 1977, J PHARMACOL-PARIS, V8, P524